Skip to main content
Download PDF

Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis

Cancer Communications volume 39, Article number: 50 (2019) Cite this article

The Original Article was published on 27 June 2019

Correction to: Cancer Commun (2019) 39:40 https://doi.org/10.1186/s40880-019-0380-x

In the original publication of this article [1], the first affiliation name in the Author details section should be updated to ‘Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China’ because the affiliation has been renamed from Jun. 15th, 2019.

Reference

  1. Liao J-F, Zhang Q, Du X-J, Lan M, Liu S, Xia Y-F, Cai X-Y, Luo W. Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis. Cancer Commun. 2019;39:40. https://doi.org/10.1186/s40880-019-0380-x.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center For Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China

    Jun-Fang Liao

  2. Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat‑sen University, Guangzhou, 510080, Guangdong, P. R. China

    Qun Zhang

  3. State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China

    Xiao-Jing Du, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai & Wei Luo

  4. Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat‑sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China

    Xiao-Jing Du, Shan Liu, Yun-Fei Xia & Wei Luo

  5. Department of Radiation Oncology, Cancer Hospital Affiliated to School of Medicine, Chengdu, 610041, Sichuan, P. R. China

    Mei Lan

  6. Department of VIP Region, Sun Yat‑sen University Cancer Center, Guangzhou, 510060, Guangdong, P. R. China

    Xiu-Yu Cai

Authors
  1. Jun-Fang Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qun Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiao-Jing Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mei Lan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yun-Fei Xia
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiu-Yu Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wei Luo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Luo.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liao, JF., Zhang, Q., Du, XJ. et al. Correction to: Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis. Cancer Commun 39, 50 (2019). https://doi.org/10.1186/s40880-019-0396-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s40880-019-0396-2

Cancer Communications

ISSN: 2523-3548

Contact us